Human papillomavirus type 16 E6 protein inhibits DNA fragmentation via interaction with DNA fragmentation factor 40

Cancer Letters

Volumn 324, Issue 1, 2012, Pages 109-117

  Jong, Jae Eun ^a   Jeong, Kwi Wan ^b   Shin, Hyokyung ^a   Hwang, Lee Rang ^a   Lee, Daeyoup ^c   Seo, Taegun ^a  

^a Dongguk University   (South Korea)

^b Gyeonggi Institute of Science and Technology Promotion   (South Korea)

^c Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

DNA fragmentation factor; E6 protein; Human papillomavirus 16

Indexed keywords

CASPASE ACTIVATED DEOXYRIBONUCLEASE; DNA; PROTEIN E6;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNA CLEAVAGE; DNA DEGRADATION; DNA FRAGMENTATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; UTERINE CERVIX CANCER; ZINC FINGER MOTIF;

AMINO ACID SEQUENCE; APOPTOSIS REGULATORY PROTEINS; DEOXYRIBONUCLEASES; DNA FRAGMENTATION; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; REPRESSOR PROTEINS; TWO-HYBRID SYSTEM TECHNIQUES; ZINC FINGERS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 84864059305     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.05.010     Document Type: Article

References (48)

1. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999, 189:12-19.
2. Longworth M.S., Laimins L.A. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol. Mol. Biol. Rev. 2004, 68:362-372.
3. Greer C.E., Wheeler C.M., Ladner M.B., Beutner K., Coyne M.Y., Liang H., Langenberg A., Yen T.S., Ralston R. Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J. Clin. Microbiol. 1995, 33:2058-2063.
4. McKaig R.G., Baric R.S., Olshan A.F. Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck 1998, 20:250-265.
5. Cheng Y.W., Chiou H.L., Sheu G.T., Hsieh L.L., Chen J.T., Chen C.Y., Su J.M., Lee H. The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res. 2001, 61:2799-2803.
6. Roy M., Morin C., Casas-Cordero M., Meisels A. Human papillomavirus and cervical lesions. Clin. Obstet. Gynecol. 1983, 26:949-967.
7. Goppinger A., Birmelin G., Ikenberg H., Elmenthaler U., Hilgarth M., Hillemanns H.G., Wied G.L. Human papillomavirus standardization and DNA cytophotometry in cervical intraepithelial neoplasia. J. Reprod. Med. 1987, 32:609-613.
8. Motoyama S., Ladines-Llave C.A., Luis Villanueva S., Maruo T. The role of human papilloma virus in the molecular biology of cervical carcinogenesis. Kobe J. Med. Sci. 2004, 50:9-19.
9. Seedorf K., Oltersdorf T., Krammer G., Rowekamp W. Identification of early proteins of the human papilloma viruses type 16 (HPV 16) and type 18 (HPV 18) in cervical carcinoma cells. EMBO J. 1987, 6:139-144.
10. Munger K., Baldwin A., Edwards K.M., Hayakawa H., Nguyen C.L., Owens M., Grace M., Huh K. Mechanisms of human papillomavirus-induced oncogenesis. J. Virol. 2004, 78:11451-11460.
11. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990, 63:1129-1136.
12. Zimmermann H., Degenkolbe R., Bernard H.U., O'Connor M.J. The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300. J. Virol. 1999, 73:6209-6219.
13. Kumar A., Zhao Y., Meng G., Zeng M., Srinivasan S., Delmolino L.M., Gao Q., Dimri G., Weber G.F., Wazer D.E., Band H., Band V. Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3. Mol. Cell. Biol. 2002, 22:5801-5812.
14. Cooper B., Schneider S., Bohl J., Jiang Y., Beaudet A., Vande Pol S. Requirement of E6AP and the features of human papillomavirus E6 necessary to support degradation of p53. Virology 2003, 306:87-99.
15. Underbrink M.P., Howie H.L., Bedard K.M., Koop J.I., Galloway D.A. E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation. J. Virol. 2008, 82:10408-10417.
16. 2+-binding fragment from the human papillomavirus type 16 E6 protein. Biochemistry 2001, 40:1196-1204.
17. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 1972, 26:239-257.
18. Haanen C., Vermes I. Apoptosis: programmed cell death in fetal development. Eur. J. Obstet. Gynecol. Reprod. Biol. 1996, 64:129-133.
19. Wyllie A.H., Kerr J.F., Currie A.R. Cell death: the significance of apoptosis. Int. Rev. Cytol. 1980, 68:251-306.
20. Wyllie A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980, 284:555-556.
21. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998, 391:43-50.
22. Liu X., Zou H., Slaughter C., Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 1997, 89:175-184.
23. Liu X., Li P., Widlak P., Zou H., Luo X., Garrard W.T., Wang X. The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis. Proc. Natl. Acad. Sci. USA 1998, 95:8461-8466.
24. Sakahira H., Enari M., Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 1998, 391:96-99.
25. Lechardeur D., Drzymala L., Sharma M., Zylka D., Kinach R., Pacia J., Hicks C., Usmani N., Rommens J.M., Lukacs G.L. Determinants of the nuclear localization of the heterodimeric DNA fragmentation factor (ICAD/CAD). J. Cell Biol. 2000, 150:321-334.
26. Widlak P., Garrard W.T. Roles of the major apoptotic nuclease-DNA fragmentation factor-in biology and disease. Cell Mol. Life Sci. 2009, 66:263-274.
27. Brustmann H. DNA fragmentation factor (DFF45): expression and prognostic value in serous ovarian cancer. Pathol. Res. Pract. 2006, 202:713-720.
28. Parton M., Krajewski S., Smith I., Krajewska M., Archer C., Naito M., Ahern R., Reed J., Dowsett M. Coordinate expression of apoptosis-associated proteins in human breast cancer before and during chemotherapy. Clin. Cancer Res. 2002, 8:2100-2108.
29. Srinivasula S.M., Ahmad M., MacFarlane M., Luo Z., Huang Z., Fernandes-Alnemri T., Alnemri E.S. Generation of constitutively active recombinant caspases-3 and -6 by rearrangement of their subunits. J. Biol. Chem. 1998, 273:10107-10111.
30. Filippova M., Parkhurst L., Duerksen-Hughes P.J. The human papillomavirus 16 E6 protein binds to Fas-associated death domain and protects cells from Fas-triggered apoptosis. J. Biol. Chem. 2004, 279:25729-25744.
31. Filippova M., Johnson M.M., Bautista M., Filippov V., Fodor N., Tungteakkhun S.S., Williams K., Duerksen-Hughes P.J. The large and small isoforms of human papillomavirus type 16 E6 bind to and differentially affect procaspase 8 stability and activity. J. Virol. 2007, 81:4116-4129.
32. Filippova M., Song H., Connolly J.L., Dermody T.S., Duerksen-Hughes P.J. The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis. J. Biol. Chem. 2002, 277:21730-21739.
33. Thomas M., Banks L. Human papillomavirus (HPV) E6 interactions with Bak are conserved amongst E6 proteins from high and low risk HPV types. J. Gen. Virol. 1999, 80(Pt 6):1513-1517.
34. Vogt M., Butz K., Dymalla S., Semzow J., Hoppe-Seyler F. Inhibition of Bax activity is crucial for the antiapoptotic function of the human papillomavirus E6 oncoprotein. Oncogene 2006, 25:4009-4015.
35. Yuan H., Fu F., Zhuo J., Wang W., Nishitani J., An D.S., Chen I.S., Liu X. Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis. Oncogene 2005, 24:5069-5078.
36. Woo E.J., Kim Y.G., Kim M.S., Han W.D., Shin S., Robinson H., Park S.Y., Oh B.H. Structural mechanism for inactivation and activation of CAD/DFF40 in the apoptotic pathway. Mol. Cell 2004, 14:531-539.
37. Widlak P., Lanuszewska J., Cary R.B., Garrard W.T. Subunit structures and stoichiometries of human DNA fragmentation factor proteins before and after induction of apoptosis. J. Biol. Chem. 2003, 278:26915-26922.
38. Charrier L., Jarry A., Toquet C., Bou-Hanna C., Chedorge M., Denis M., Vallette G., Laboisse C.L. Growth phase-dependent expression of ICAD-L/DFF45 modulates the pattern of apoptosis in human colonic cancer cells. Cancer Res. 2002, 62:2169-2174.
39. Hsieh S.Y., Chen W.Y., Yeh T.S., Sheen I.S., Huang S.F. High-frequency Alu-mediated genomic recombination/deletion within the caspase-activated DNase gene in human hepatoma. Oncogene 2005, 24:6584-6589.
40. Yan B., Wang H., Peng Y., Hu Y., Zhang X., Chen Q., Bedford J.S., Dewhirst M.W., Li C.Y. A unique role of the DNA fragmentation factor in maintaining genomic stability. Proc. Natl. Acad. Sci. USA 2006, 103:1504-1509.
41. Ahn J.Y., Liu X., Cheng D., Peng J., Chan P.K., Wade P.A., Ye K. Nucleophosmin/B23, a nuclear PI(3,4,5)P(3) receptor, mediates the antiapoptotic actions of NGF by inhibiting CAD. Mol. Cell 2005, 18:435-445.
42. Ahn J.Y., Liu X., Liu Z., Pereira L., Cheng D., Peng J., Wade P.A., Hamburger A.W., Ye K. Nuclear Akt associates with PKC-phosphorylated Ebp1, preventing DNA fragmentation by inhibition of caspase-activated DNase. EMBO J. 2006, 25:2083-2095.
43. Omata K., Suzuki R., Masaki T., Miyamura T., Satoh T., Suzuki T. Identification and characterization of the human inhibitor of caspase-activated DNase gene promoter. Apoptosis 2008, 13:929-937.
44. Yim E.K., Lee K.H., Myeong J., Tong S.Y., Um S.J., Park J.S. Novel interaction between HPV E6 and BARD1 (BRCA1-associated ring domain 1) and its biologic roles. DNA Cell Biol. 2007, 26:753-761.
45. Ronco L.V., Karpova A.Y., Vidal M., Howley P.M. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 1998, 12:2061-2072.
46. Grm H.S., Banks L. Degradation of hDlg and MAGIs by human papillomavirus E6 is E6-AP-independent. J. Gen. Virol. 2004, 85:2815-2819.
47. Latorre I.J., Roh M.H., Frese K.K., Weiss R.S., Margolis B., Javier R.T. Viral oncoprotein-induced mislocalization of select PDZ proteins disrupts tight junctions and causes polarity defects in epithelial cells. J. Cell Sci. 2005, 118:4283-4293.
48. Inohara N., Koseki T., Chen S., Benedict M.A., Nunez G. Identification of regulatory and catalytic domains in the apoptosis nuclease DFF40/CAD. J. Biol. Chem. 1999, 274:270-274.